Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals

• Status: Completed
• Trial end date: 2020-02-05
• Target enrollment: 0
• Participant gender: All

Summary

This clinical trial studies how well positron emission tomography (PET)/computed tomography (CT) works compared to PET/magnetic resonance imaging (MRI) in evaluating patients with cancer. PET/CT and PET/MRI may determine which scanner is best for the patient's type of cancer and other types of cancers.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Stanford University
• Treatments: Fluorodeoxyglucose F18

Criteria

INCLUSION CRITERIA

• Cancer diagnosis

• Capable of complying with study procedures

• Able to remain still for duration of imaging procedure (approximately 90 minutes total)

• Written informed consent

EXCLUSION CRITERIA

• Pregnant or nursing

• Metallic implants

• Impaired renal function